Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.00K | -114.20K | -84.40K | -95.90K | -40.20K |
| Total Depreciation and Amortization | 31.60K | 20.20K | 19.50K | 19.60K | 19.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.50K | -5.90K | 6.80K | 6.80K | 7.70K |
| Change in Net Operating Assets | -5.20K | 94.10K | 45.30K | 77.90K | 11.80K |
| Cash from Operations | 2.90K | -5.80K | -12.80K | 8.50K | -900.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4.50K | 37.40K | 1.90K | -- | -- |
| Total Debt Repaid | -- | -44.00K | 20.50K | -9.30K | -11.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.20K | -4.80K | 16.40K | -6.90K | -8.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.10K | -10.50K | 3.50K | 1.60K | -9.20K |